文献速递细菌感染、耐药与抗菌药物

标准化抗菌药物使用比值:衡量和比较抗生素使用的新指标

The Standardized Antimicrobial Administration Ratio: A New Metric for Measuring and Comparing Antibiotic Use.
PubMed 文献 · Clin Infect Dis · 2018-01-01

美国CDC开发了标准化抗菌药物使用比值(SAAR),用于汇总抗生素使用(AU)并进行风险调整,使医院能够追踪AU随时间的变化并与国家基准比较。SAAR为观察值与预测值之比,预测值由统计模型估算,SAAR为1表示观察使用与预测使用相等。大多数地点级SAAR与1有统计学显著差异,成人地点SAAR低至比1低52%、高至比1高41%,成人和儿科ICU的SAAR中位数为0.667-1.119。

要点

  • SAAR是观察值与预测值之比,预测值由统计模型估算,SAAR为1表示观察使用与预测使用相等。
  • SAAR覆盖五个抗菌药物类别:主要用于医院获得性/多重耐药菌的广谱药物、主要用于社区获得性感染的广谱药物、抗MRSA药物、主要用于手术部位感染预防的药物和所有抗生素。
  • 大多数地点级SAAR与1有统计学显著差异,成人地点SAAR低至比1低52%、高至比1高41%。

核心结论

  • 这是首个使用电子报告至国家监测系统的即时抗菌药物给药数据、实现跨医院风险调整AU比较的汇总AU指标。
  • SAAR获得国家质量论坛认可,提供AU基准,管理项目可用于推动改进。

研究设计与样本

  • 医院向国家医疗安全网络(NHSN)AU选项报告,以每患者住院日的抗菌药物治疗天数形式电子提交汇总AU数据。
  • SAAR针对特定NHSN成人和儿科患者护理地点开发,覆盖五个抗菌药物类别。

主要发现

  • 大多数地点级SAAR与1有统计学显著差异:成人地点SAAR低至比1低52%、高至比1高41%。
  • 成人和儿科ICU的SAAR中位数范围为0.667-1.119。
  • SAAR分布可作为与国家SAAR比较的外部参照。

临床怎么用

  • SAAR提供AU基准,管理项目可用于帮助推动改进。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To provide a standardized, risk-adjusted method for summarizing antibiotic use (AU), enable hospitals to track their AU over time and compare their AU data to national benchmarks, the Centers for Disease Control and Prevention developed the Standardized Antimicrobial Administration Ratio (SAAR). METHODS: Hospitals reporting to the National Healthcare Safety Network (NHSN) AU Option collect and submit aggregated AU data electronically as antimicrobial days of therapy per patient days present. SAARs were developed for specific NHSN adult and pediatric patient care locations and cover five antimicrobial agent categories: (1) broad-spectrum agents predominantly used for hospital-onset/multi-drug resistant bacteria; (2) broad-spectrum agents predominantly used for community-acquired infections; (3) anti-methicillin-resistant Staphylococcus aureus agents; (4) agents predominantly used for surgical site infection prophylaxis; and (5) all antibiotic agents. The SAAR is an observed-to-predicted use ratio where predicted use is estimated from a statistical model; a SAAR of 1 indicates that observed use and predicted use are equal. RESULTS: Most location-level SAARs were statistically significantly different than 1: adult locations up to 52% lower than 1 and up to 41% higher than 1. Median SAARs in adult and pediatric ICUs had a range of 0.667-1.119. SAAR distributions serve as an external comparison to national SAARs. CONCLUSIONS: This is the first aggregate AU metric that uses point-of-care, antimicrobial administration data electronically reported to a national surveillance system to enable risk-adjusted, AU comparisons across multiple hospitals. Endorsed by the National Quality Forum, SAARs provide AU benchmarks that stewardship programs can use to help drive improvements.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. van Santen KL, Edwards JR, Webb AK, et al. The Standardized Antimicrobial Administration Ratio: A New Metric for Measuring and Comparing Antibiotic Use. Clin Infect Dis. 2018. PMID: 29409000. doi:10.1093/cid/ciy075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。